Patients with cancer treated through the Department of Veterans Affairs are less likely to receive excessive end-of-life interventions than patients treated through Medicare.
quality of care
Citing a growing rift between the needs of patients with cancer and the actual care they receive, ESMO highlighted a need for better supportive and palliative care in a recent position paper.
Earlier access to palliative care may increase the likelihood that patients with hematologic malignancies nearing end-of-life can die at home.
Receipt of treatment for multiple myeloma varies greatly among racial or ethnic minorities.
A recent comparative study examined predictors of discharge location for patients with advanced cancer and assessed the relationship between discharge location and survival.
Integrating lay navigators into a cancer care network reduced hospitalizations by 8% per quarter and accounted for $19 million in annual savings for Medicare.
A recent study demonstrated meaningful clinical activity with limited toxicity in patients with soft-tissue and bone sarcoma after treatment with an immuno-agent.
The International Association for the Study of Lung Cancer has published its first version of the Atlas of EGFR Testing in Lung Cancer.
Researchers developed a novel gene signature that has prognostic value in patients with multiple myeloma who are treated with immunomodulatory derivatives.
A recent study compared the safety and efficacy of multiple chemotherapy agents in treating advanced liposarcoma.